Sergio Traversa
CEO at Relmada Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Relmada Therapeutics Inc., 3 years.
Relmada Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 31, 2024 | Relmada Therapeutics Inc. | Open-market purchase | +27,460 | $4.00 | $109,840 |
| Jan 30, 2024 | Relmada Therapeutics Inc. | Open-market purchase | +40,999 | $3.90 | $159,896 |
| Jan 29, 2024 | Relmada Therapeutics Inc. | Open-market purchase | +31,541 | $3.71 | $117,017 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.